1. Introduction {#sec0005}
===============

Diabetes mellitus (DM) is a major clinical and public health problem worldwide \[[@bib0005], [@bib0010], [@bib0015]\] with equal rates in both women and men \[[@bib0015]\]. DM is a clinically and genetically heterogeneous group of disorders characterized by abnormally high levels of glucose in the blood. Hyperglycaemia is due to deficiency of insulin secretion or to resistance of the body's cells to the action of insulin, or a combination of these. Often there are also disturbances of carbohydrates, fat, and protein metabolism \[[@bib0040]\]. The criteria for the classification and diagnosis of DM are as follows:

Type I: caused by β-cell destruction, often immune mediated, that leads to loss of insulin secretion and absolute insulin deficiency.

Type II: caused by a combination of genetic and sporadic factors that result in insulin resistance and insulin deficiency. The specific genes are unknown but have been under intense investigation. Sporadic factors include aging, high caloric intake, overweight, central adiposity, sedentary lifestyle, and low birth weight.

Other specific types: These comprise a heterogeneous etiologic group that include cases in which the causes are uncovered or partially known. The later includes known genetic defects affecting β-cell function or insulin action, diseases of exocrine pancreas, endocrinopathies, drug-or chemical-induced pancreatic changes, diseases and conditions in which the incidence of diabetes is substantially elevated but a precise aetiology has not been established.

Gestational diabetes: caused by insulin resistance and relative insulin deficiency associated with pregnancy \[[@bib0045]\].

Oxidative stress is a pathogenetic mechanism in diabetic complications \[[@bib0020], [@bib0025], [@bib0030], [@bib0035]\]. Long-term effects of diabetes include glycation of proteins, increased risk of cardiovascular diseases, atherosclerosis, retinopathy, nephropathy, and neurological dysfunctions \[[@bib0020], [@bib0025], [@bib0030], [@bib0035]\]. Hyperglycaemia is a widely known cause of enhanced free radical concentration. The generation of reactive oxygen species (ROS) has shown increment in DM patients \[[@bib0050]\].

Although streptozotocin (STZ) is preferable than alloxan in induction of DM, alloxan-induced diabetes is very widely used and acceptable disease model \[[@bib0055]\]. The procedure for chemical induction of DM proved to be effective \[[@bib0060]\]. Alloxan-induced DM experimental model adds to various others \[[@bib0065], [@bib0070]\] and can be used as alternative model in studies carried out in several fields such as plastic surgery \[[@bib0075]\]. Accumulating evidence showed that "alloxan is comparable to STZ" \[[@bib0080]\]. Evidence for upregulated oxidative stress responses in diabetes includes observations of decreased plasma antioxidant concentrations in both diabetic subjects \[[@bib0085]\] and animal models \[[@bib0090]\]. Mechanisms that contribute to increased oxidative stress in diabetes have been reviewed \[[@bib0020], [@bib0095], [@bib0100]\]. In addition, glycation in DM modifies lipids, lipoproteins as in the case of apo B and low density lipoprotein (LDL) \[[@bib0105]\], and increases the susceptibility of LDL to oxidation \[[@bib0110]\].

Tissue GSH and thiols (-SH) are the ultimate bastion against oxidative stress and tissue injury, and are maintained in the reduced state by the concerted action of tissue tocopherols and other reducing factors such as urates \[[@bib0115]\].

GSH is the most abundant non-protein thiol in mammalian cells \[[@bib0120]\]. It is a tripeptide, γ-glutamylcycteinylglycine. It has two structural features responsible for much of its biochemical functions. They are its thiol group (-SH due to cysteine) and the γ-glutamyl bond (linking cysteine to glutamate). The −SH is responsible for most of the catalytic and reactive properties of GSH. It confers of GSH the ability to participate in both oxidation-reduction reactions. Thus it occurs both in reduced GSH and oxidized GSSG forms \[[@bib0125]\].

GSH is the major intracellular redox buffer in almost all cell types \[[@bib0130], [@bib0135]\]. A relatively high concentration of GSH is present in β-cells \[[@bib0140]\]. GSH plays a central role in the cellular defence against chemical and ROS injury \[[@bib0145]\], because of its role in xenobiotic detoxification and free radical metabolism. i.e. GSH serves as a substrate for the GSH-S-transferase that catalyzes the addition of −SH group of GSH to the activated intermediate of various xenobiotics, thereby facilitating their excretion from the cell \[[@bib0150]\]. Additionally, GSH is used by GSH peroxidase to reduce H~2~O~2~ and other hyderoperoxides to less destructive metabolites \[[@bib0155]\]. Furthermore, GSH is a cosubstrate in destroying hyderoperoxide fatty acids located in phospholipids \[[@bib0160]\].

GSH is also a scavenger of •OH radical and singlet O~2~, in the case of •OH radical, the thiyl radical is generated \[[@bib0165]\]. In addition, serum −SH groups act as an important extracellular scavengers of peroxides and are therefore helpful in protecting the surrounding tissues \[[@bib0170]\]. Thiol compounds also could prevent Millard reaction *in vitro* \[[@bib0175]\]. The GSH redox cycle is a major determinant of the antioxidative capacity of plasma and its constituents \[[@bib0180]\]. A decrease in the levels of both plasma and intracellular antioxidants such as GSH, vitamin E, −SH and ascorbate has been demonstrated in both types of DM \[[@bib0185]\]. GSH has beneficial effects against diabetes-induced nerve damages and was shown to decrease in nerves \[[@bib0110]\]. Blood GSH was significantly reduced by 25% at the first two years of diagnosis of type II diabetes. Moreover, a progressive decline of GSH was associated with the increased peroxidation \[[@bib0190]\], while plasma GSH was reduced by 50% \[[@bib0180]\]. This was also found in chronic diabetes for longer periods \[[@bib0195], [@bib0200]\].

Isoflavones are a subclass of the more ubiquitous flavonoids. The primary isoflavones in soybeans are genistein and daidzein and their respective glycosides, genistin and daidzin \[[@bib0275]\].

In western countries, beans play only a minor dietary role despite the fact that they are low in fat and are excellent sources of protein, dietary fibers, and a variety of micronutrients and phytochemicals. Dry beans and soy foods offer benefits in the prevention of diabetes and in the clinical management of established diabetes \[[@bib0205]\]. Cereal fibers have long attracted attention in relation to the prevention of chronic diseases \[[@bib0210]\]. Whole grains and wheat germ are the richest dietary sources of α-Tocopherols \[[@bib0215]\].

Heat processing, enzymatic hydrolysis, and fermentation, can significantly alter the isomeric distribution of the three major isoflavones in soy and broadbean \[[@bib0220], [@bib0225], [@bib0230]\]. Germination is an alternative process for the improvement of protein quality of legumes. Although antioxidants supplementation may be of benefit to diabetic patients, it may be associated with risks i.e.: excessive antioxidant treatment may impair vascular function in small mesenteric arteries of STZ-diabetic rats \[[@bib0235]\]. For this reason, considerable attention has been focused on possible protective factors in the diet. We aim to assess the impact of naturally occurring phytochemicals after being processed by germination, heat-processing and drying, on the oxidative metabolism in AD rats.

2. Materials and methods {#sec0010}
========================

Seeds were prepared either by germination, heat treatment or drying. After soaking in water for 8 h \[[@bib0240]\], soybean was germinated for 3 days at 25 °C while broadbean for 2 days at 20 °C \[[@bib0245]\]. Heat treatment for soybean and broadbean was carried out in a water bath at 90 °C for 10 min\[[@bib0250]\]. Dried wheat was used directly without treatment. All seeds were then dehulled, dried at 50 °C, and ground into a fine powder. The six types of flours were conducted to proximate analysis of major neutrients (total proteins and fats). [Table 3](#tbl0015){ref-type="table"} shows the chemical constituents of the experimented seeds (g/100g). Total fat content was determined by Soxhelt method \[[@bib0255]\], protein content of dry base was determined by macro Kjeldahl method \[[@bib0260]\], by multiplying protein nitrogen (N) × 6.25 in case of soybean and broadbean, while (N) × 5.7 in case of wheat. Ash and fiber were determined according to \[[@bib0265]\]. The antioxidant composition of the experimental legumes and seeds is published \[[@bib0230], [@bib0270], [@bib0275]\]. Most of the isoflavones (99%) occurs as 7-0-monoglucosides, of which genistin, daidzin and glycitin accounts approximately for 64%, 23%, and 13% respectively \[[@bib0280], [@bib0285]\]. Song et al. \[[@bib0290]\] found that the total isoflavone content in soygerm equal 23201 μg/g. Also, they referred to that soybeans and soy products contain about 1--3 mg isoflavones/g protein. Whole grain cereals antioxidant concertation was compared with the standard antioxidant Trolox and was expressed as Trolox equivalents (as 1 mM) concentration \[[@bib0295]\]. Each 100 g of cereals were found to contain 2200--3500 Trolox equivalents. The most recently studied class is lignin.

2.1. Experimental design {#sec0015}
------------------------

All protocols were approved by Ain Shams University at Cairo, Egypt. Adult male albino rats (Sprague-Dawely) weighing 200--250 g were used. Rats were housed individually in mesh bottom metallic cages and were fed a control "basal" diet, [Table 1](#tbl0005){ref-type="table"}, for 1 week as an adaptation period. Antioxidants content in soy is in the oil portion. All diets contained 10% oil and 10% protein at the expense of starch. Diabetes was induced by intraperitoneal injection of freshly prepared alloxan monohydrate solution in saline at a dose level of 150 mg/kg body weight \[[@bib0300]\]. Five days after alloxan injection, blood samples were collected by amputation of the tail tip of all surviving animals and the blood glucose levels were determined using a Haemo-Gluco test and a glucometer (Boehringer Mannheim). Rats with blood sugar levels \>200 mg/dl were considered diabetic and were employed in the study. Diabetic rats were then divided into 7 groups as shown in [Table 2](#tbl0010){ref-type="table"} . Body weight of all rats and food intake were recorded at weekly intervals to monitor the average body weight changes, [Fig. 1](#fig0005){ref-type="fig"}(A).Table 1Composition of control and experimental diets.Table 1ConstituentsDietExperimental diets(g/100 g diet)Control diet[b](#tblfn0010){ref-type="table-fn"}123456Casein13------------Germinated soybean[a](#tblfn0005){ref-type="table-fn"}--60----------Heat-processed soybean[a](#tblfn0005){ref-type="table-fn"}----37--------Germinated broadbean------94----Heat-processed broadbean--------43----Germinated whole wheat----------139--Dried whole wheat------------79Sunflower oil (ml)104410101010Salt mixture[c](#tblfn0015){ref-type="table-fn"}4444444Vitamin mixture[d](#tblfn0020){ref-type="table-fn"}1111111Cellulose5555555Cornstarch672649--37--1[^1][^2][^3][^4][^5][^6]Table 2Experimental groups.Table 2G1 (7)Normal control rats fed 10% protein (casein)G5 (7)Fed 10% protein (germinated broadbean)G2 (7)Diabetic control rats fed 10% protein (casein)G6 (12)Fed 10% protein (heat-processed broadbean)G3 (7)Fed 10% protein (germinated soybean)G7 (6)Fed 10% protein (germinated whole wheat)G4 (8)Fed 10% protein (heat-processed soybean)G8 (6)Fed 10% protein (dried whole wheat)[^7]Table 3The chemical constituents of the experimented seeds (g/100g).Table 3Seed type and treatmentMoistureProteinFatCarbohydrates (by difference)AshFiberHeat-treated soy33.23526.7516.3817.233.452.93Germinated soy58.3216.710.2210.772.161.83Heat-treated broadbean18.1723.351.2544.212.784.67Germinated broadbean62.7510.630.6322.441.412.13Germinated wheat49.27.191.0641.330.031.19Dried wheat10.2712.71.8773.010.052.10Fig. 1Effect of experimental diets on: A) body weight changes; B) relative organs weights (mean ± SEM).Fig. 1

2.2. Biochemical analysis {#sec0020}
-------------------------

At the end of the experimental period, animals were fasted overnight, anesthetized with diethyl ether and sacrificed. Blood samples were collected from posterior vena cava in heparinized and non-heparinized tubes. Immediately after sacrificing, organs (liver, kidney, heart, spleen and testes) were plotted free of adhering blood, washed with cold saline, dried between filter papers and weighed. Plasma and serum were separated by centrifugation at 3000 r.p.m. for 15 mins. Fresh serum was used for the determination of serum glucose and protein thiol. Plasma aliquots were frozen at −10°С until further determinations of other parameters. After separation of plasma the red blood cells of 2 ml blood were washed twice with cold saline and an aliquot of packed cells were diluted with cold distilled water. An ethanol-chloroform extract was prepared for the assay of SOD activity as will be described later.

Non-heparinized blood was centrifuged and the separated serum was used for estimation of uric acid (UA), and protein −SH content after \[[@bib0305], [@bib0310], [@bib0315]\] respectively. Heparinized blood was centrifuged at 3000 r.p.m and plasma was used for α-T determination using High Pressure Liquid Chromatography (HPLC) after \[[@bib0320]\]. Erythrocytes Cu-Zn SOD was assayed in saline-washed red blood cells using the method described by \[[@bib0325]\]. Immediately after sacrificing rats, their livers were excised, plotted free of adhering blood and washed with cold saline. Liver tissue preparation: Three tiny weighed portions (≈1 g) were homogenized separatly. The first portion was homogenized in 1.15% KCl, the second in M/15 phosphate buffer pH 7, and the third portion in 3% ice-cold metaphosphoric acid to make 10% W/V liver homogenate which was used for the determination of MDA according to \[[@bib0330]\], CAT according to \[[@bib0335]\], and GSH according to \[[@bib0340]\]. Protein content of the liver was estimated by the method of \[[@bib0345]\]. Plasma was used for the determination of TAGs \[[@bib0350]\], HDL \[[@bib0355]\], LDL \[[@bib0360]\] and total cholesterol \[[@bib0365]\] levels using enzymatic kits provided by bioMérieux, France.

2.3. Determination of MDA in the liver homogenate {#sec0025}
-------------------------------------------------

Lipohydroperoxides or MDA precursor reacts with thiobarbituric acid (TBA) in an acid medium containing phosphoric acid (at pH 2) to produce colored TBA complex that is measured colorimetrically from the difference in the readings at two wavelengths 535 and 520 nm, according to Uchiyama and Mihara \[[@bib0330]\].

2.4. Determination of fasting serum glucose {#sec0030}
-------------------------------------------

The pink color formed in the enzymatic determination of glucose depends on the reaction described by Trinder \[[@bib0305]\]. The kit was provided from bioMérieux, Sa, France. The absorbance of sample was read against the blank at 505 nm within 30 mins.

2.5. Determination of protein thiol in serum {#sec0035}
--------------------------------------------

Protein-SH groups react with 5,5′-dithiobis-(2-nitrobenzoic acid) \[DTNB-Ellman\'s reagent\] at pH 7.4 to give a colored product, 5-thio-2-nitrobenzoic acid (NBA), which is measured colorimetrically at 412 nm. The method was described by Koster et al. \[[@bib0315]\].

2.6. Determination of serum UA {#sec0040}
------------------------------

The pink color formed in the enzymatic determination of UA depends on two step reactions: in the first step allantoin is formed by the effect of uricase on UA, and in the second step 3,5 dichloro-2-hydroxybenzene-sulfonic acid reacts with 4-aminoantipyrine in the presense of peroxidase to form chromogen. The absorbance of the latter is read against the blank at 520 nm within 30 mins., according to Artiss and Entwistle \[[@bib0310]\]. The kit was provided from bioMérieux, Sa, France.

2.7. Determination of GSH in the liver homogenate {#sec0045}
-------------------------------------------------

Determination of reduced GSH and non-protein-SH groups is based on the development of stable yellow color when 5,5\'-dithiobis-(2-nitrobenzoic acid) (DTNB) is added to sulfhydril compounds. This color is related to the amount of GSH. The method is described by Beutler et al. \[[@bib0340]\].

2.8. Determination of protein in the liver homogenate {#sec0050}
-----------------------------------------------------

The reduction of phosphomolybdic-phosphotungestic reagent by the copper-treated protein in alkaline medium at room temperature, results in the formation of blue color that is measured spectrophotometrically at 500 nm. The method was described by Lowry et al. \[[@bib0345]\].

2.9. Determination of CAT activity/g protein in the liver homogenate {#sec0055}
--------------------------------------------------------------------

The ultraviolet absorbtion of H~2~O~2~ solution is easily measured between 230 and 250 nm. On decomposition of H~2~O~2~ with CAT, the absorption decreases with time and from this decrease the enzyme activity can be calculated. This method can only be used with enzyme solutions which do not absorb strongly at 230--250 nm. The method was described by Maehly and Chance \[[@bib0335]\]. One unit of CAT activity is the amount of enzyme which liberates half the peroxide oxygen from an H~2~O~2~ solution of any concentration in 100 s at 25°С.

2.10. Determination of eSOD activity {#sec0060}
------------------------------------

The determination of eSOD activity is based on the ability of the enzyme to inhibit the reduction of nitroblue tetrazolium (NBT), (i.e. to inhibit formazan formation), by the superoxides generated in the reaction of photoreduced riboflavin and oxygen. The method was described by Winterbourn et al. \[[@bib0325]\].

2.11. Determination of plasma α-T by HPLC {#sec0065}
-----------------------------------------

The method was described by Bieri et al. \[[@bib0320]\]. Plasma was deprotinized with ethanol, and the lipid was extracted with hexane. After an aliquot of the solvent phase was evaporated, the residue was dissolved in ethanol. A portion of the solution was injected into a C~18~ reversed-phase chromatographic column, and the absorbance of the vitamins and standard were measured at 285 nm. α-T is quantified by applying the peak area ratio method.

### 2.11.1. Liquid chromatograph {#sec0070}

Model 204 with model 6000-solvent delivery system, a U6K universal injector, and model 440-absorbance detector (all from Waters Associates, Inc., Milford, Massachusetts).

### 2.11.2. Chromatographic column {#sec0075}

Reversed-phase U Bondapk C~18~

### 2.11.3. Standard curve and calculation {#sec0080}

Constant amount of α-tocopheryl acetate was combined with variable amount of the corresponding alcohol form of the vitamin to give solutions with a three-fold range of weight ratios. These solutions were chromatographed and the peak-area ratios were recorded.

2.12. Determination of plasma TAGs concentration {#sec0085}
------------------------------------------------

The pink color formed in the enzymatic determination of TAGs depends on the reaction described by Fossati and Prencipe \[[@bib0350]\]. The kit was provided from bioMérieux, Sa, France. The absorbance of sample was read against the blank at 505 nm within 30 mins.

2.13. Determination of plasma total cholesterol {#sec0090}
-----------------------------------------------

The pink color formed in the enzymatic determination of total cholesterol is based on the reaction described by Allain et al. \[[@bib0365]\]. The test kit was provided from bioMérieux, Sa, France. The absorbance of sample was read against the blank at 500 nm within 30 mins.

2.14. Determination of plasma HDL cholesterol {#sec0095}
---------------------------------------------

The chylomicrons and lipoproteins of very low density (VLDL) and low density (LDL) contained in the sample are precipitated by the addition of phosphotungestic acid in the presence of magnesium ions. The supernatant obtained after centrifugation contains HDL, from which cholesterol can be determined enzymatically as was described by Burstein et al. \[[@bib0355]\]. The absorbance of sample was read against the blank at 500 nm within 30 mins. The kit was provided from bioMérieux, Sa, France.

2.15. Calculation of plasma LDL cholesterol concentration {#sec0100}
---------------------------------------------------------

The method used for determining LDL involves an equation in which the VLDL is estimated from the TAGs concentration in plasma. The equation used was developed by Friedewald et al. \[[@bib0360]\] where the TAGs value is divided by 5 when measurements are in units of mg/dl to give VLDL. The LDL is then estimated by subtraction from total cholesterol concentration as follows:

2.16. Statistical analysis {#sec0105}
--------------------------

Statistical analysis of data was accomplished using the Statistical Package for Social Sciences (SPSS) for Microsoft Windows release 8.0 statistical software package. The Bonferroni t-test was used for multiple comparison at a significance level of Alpha p \< 0.05, p \< 0.01, p \< 0.001. All values are expressed as Mean ± Standard Error of the Mean (SEM).

3. Results {#sec0110}
==========

As compared with initial body weight, final body weight of normal control group was increased, while that of all diabetic control group was decreased, [Fig. 1](#fig0005){ref-type="fig"}(A). Normal and diabetic rats did not score difference in food intake, [Fig. 1](#fig0005){ref-type="fig"}(B).

As shown in [Fig. 2](#fig0010){ref-type="fig"}(A), germinated soybean induced the most predominant effect in normalizing fasting serum glucoe level of diabetic rats. Serum glucose levels of germinated soy or whole wheat-fed groups were significantly lower as compared to the diabetic control group. The elevated hepatic MDA of diabetic rats decreased significantly in groups fed heat-treated soybean, germinated broadbean and wheat-based diets compared to the diabetic control. The most favorable effect in reducing hepatic MDA levels was achived by whole-wheat and heat processed soy, [Fig. 2](#fig0010){ref-type="fig"}(B).Fig. 2Effect of experimental diets on: A) fasting serum glucose; B) hepatic MDA levels (mean ± SEM).Fig. 2

Whole wheat restored the diminshed hepatic GSH content of the diabetic control rats and most favorably by dried wheat, [Fig. 3](#fig0015){ref-type="fig"}(A). The rest of the experimental diets induced similar reduction in hepatic GSH from the normal and diabetic controls. Hepatic CAT activity was significantly decreased in all diabetic groups as compared to the normal control group, [Fig. 3](#fig0015){ref-type="fig"}(B). The tested diets have no significant effect on CAT activity compared to the diabetic control group. All the experimental diets restored eSOD levels to baseline values and even above such values [Fig. 3](#fig0015){ref-type="fig"}(C). Heat-processed soybean and dried wheat induced the most favorable increase in eSOD compared to the diabetic control group.Fig. 3Effect of experimental diets on: A) hepatic GSH levels; B) hepatic CAT; C) eSOD activities (mean ± SEM).Fig. 3

[Fig. 4](#fig0020){ref-type="fig"}(A) showed that diabetes induced significant reduction in protein −SHs levels compared to normal control. Such reduction was restored to normal levels by all experimental diets. Our results showed that diabetes did not change serum UA levels from normal, [Fig. 4](#fig0020){ref-type="fig"}(B). Germinated soybean, heat-processed broadbean and dried wheat-based diets reduced serum UA compared to the diabetic control significantly, whereas dried wheat normalized such level. Diabetes induced a significant elevation of plasma α-T levels compared to normal control, and the most predominant increase above the baseline value was induced by dried wheat. Such elevation was reduced significantly compared to diabetic control group by soybean and heat-treated broadbean.Fig. 4Effect of experimental diets on: A) serum protein--SH; B) serum UA; C) plasma α-T (Mean ± SEM).Fig. 4

Diabetes did not change TAGs levels compared to normal, [Fig. 5](#fig0025){ref-type="fig"}(A). Comparing to normal control, plasma total-, HDL- and LDL-cholesterol levels of diabetic control were significantly elevated by 27%, 32%, and 38% respectively, [Fig. 5](#fig0025){ref-type="fig"}(B). This increase tended to decline significantly by the experimental diets compared to diabetic control.Fig. 5Effect of experimental diets on: A) plasma TAGs; B) plasma total, HDL- and LDL-cholesterol of normal and diabetic rats (means ± SEM).Fig. 5

Soybeans and whole wheat had a strong lowering effect on TAGs and even normalized TAGs levels. Germinated soy caused the most favorable TAGs-lowering effect than heat-processed soy. Germinated and dried wheat induced similar effects on lowering TAGs. Broadbeans did not have such effect.

Soybeans and wheat also had a significant lowering effect on total cholesterol, but only if germinated. Significant reduction was observed in plasma total cholesterol in germinated soy group (by 28%) and germinated wheat group (by 34%) as compared to the diabetic control group.

The experimental diets did not improve plasma HDL-cholesterol compared to diabetic control rats, and induced HDL-cholesterol levels comparable to normal, except heat-processed broadbean that reduced HDL- significantly from both normal and diabetic control groups. Germinated wheat induced the most favorable effect in reducing LDL-cholesterol than the diabetic control group.

4. Discussion {#sec0115}
=============

We found that food intake did not change in diabetic and normal controls. Final body weights of diabetic rats were decreased, except for the group fed dried wheat as compared to their initial weights. This may result from impaired utilization of nutrients. The reduction in body weight of diabetic rats agrees with the findings of \[[@bib0235], [@bib0370], [@bib0375]\]. The liver, kidney, heart, and testes hypertrophied in most diabetic groups compared to normal control, and this was more evident in the kidney relative weights. Similar findings have been reported in several studies \[[@bib0380], [@bib0385], [@bib0390]\] which support the present data. This may be attributed to the polydipsia. Our data showed normalized kidney and liver relative weights of all experimental groups compared to the diabetic control group. Substituting soy protein for animal protein in diabetic patients diets was shown to be effective in reversing or slowing the progression of established kidney disease. This results in less hyperfiltration and glomerular hypertension and, therefore, resultant protection from diabetic nephropathy \[[@bib0395]\]. This may explain the noticed improvement in the kidney relative weights of animals fed germinated soybean, since thier serum glucose level was normalized. Limited evidence suggests that drybeans-induced protection may also have renal protective effects \[[@bib0400]\]. More investigation of this area is required.

Although measuring the antioxidant content would have been informative of the level at which ameliorative effects are achieved, we confirm that feeding the whole food reduced the diabetic hyperglycaemia in our study to variable levels and in a diet-dependent manner. The dietary intervention used in this study improved serum glucose of diabetic rats being more evident in germinated soybean and wheat, heat-processed soybean and dried wheat groups. The normalization of serum glucose level observed in diabetic rats fed germinated soybean diet is consistent with the findings of \[[@bib0405], [@bib0410], [@bib0415], [@bib0420]\]. In this study, a germinated soybean diet is more effective than boiled soybean in ameliorating serum glucose levels of diabetic rats. Whole wheat-based diets improved hyperglycaemia in the present study. This effect may be related to the wide range of nutrients and phytochemicals in the whole grain that may work synergistically to optimize animal health \[[@bib0425]\], and improve insulin sensitivity \[[@bib0430]\].

lipid peroxidation is a free radical-related process that in biologic systems may occure under enzymatic control, or non-enzymatically. This latter form is associated mostly with cellular damage as a result of oxidative stress \[[@bib0435]\]. The primary targets for attack by oxygen free radicals are the polyunsaturated fatty acids (PUFAs) of membrane phospholipids. However, attack of LDL-PUFAs should be also considered \[[@bib0165]\]. The reaction then proceeds through 3 stages as depicted in Slater \[[@bib0440]\].

The enzymes lipoxygenase, cyclooxygenase and peroxidase promote the controlled peroxidation of fatty acids to generate hydroperoxides and endoperoxides. Hydroperoxides degrade to various secondary products including hydroxy-fatty acids, epoxides and scission products such as aldehydes, including malondialdehydes, ketons, and lactones, many of which are toxic \[[@bib0445]\]. Other products are alkenals and hydroxy alkenals such as 4-hydroxynonenal \[[@bib0450]\] and hydrocarbon-expressing genes as pentane \[[@bib0455]\]. As well as 8-isoprostaglandin F2α \[[@bib0460]\]. The consequences of the peroxidation of membrane lipids include loss of PUFAs, decreased lipid fluidity, alterations in membrane permeability and membrane-associated enzymes, ion transport, substance release from the subcellular compartment and the generation of cytotoxic metabolites of lipid hydroperoxides \[[@bib0465]\].

MDA is a widely used marker of lipid peroxidation \[[@bib0470]\]. Kędziora-kornatowska et al. \[[@bib0475]\] reported that MDA content was significantly elevated in erythroctyes of type II diabetic patients versus the control group. In addition, lipid peroxidation data presented by TBA reactive substrates (TBARS) in plasma were found to be elevated by 80% in the early stages of diabetes in human, with time-dependent progressive increases \[[@bib0480]\].

The present data revealed alloxan-induced marked oxidative impact. The changes observed in the parameters measured in the liver are in accordance with other studies \[[@bib0235], [@bib0480], [@bib0485], [@bib0490]\]. In our study, the observed increment in hepatic MDA was normalized in dried wheat fed rats, and partially improved by heat-processed soybean, germinated broadbean and dried wheat. The reported effects might be due to the reduced hyperglycaemia-induced oxidative stress in such groups. Astuti \[[@bib0495]\] found that tempeh (a fermented soy product) was able to inhibit lipid peroxidation, suggested to be through the direct antioxidant effect of isoflavonoid in tempeh and through iron binding capability of isoflavonoids into chelate complexes, which then inhibit iron catalyzing effect in lipid peroxidation.

Nutritional status may infleunce tissue GSH levels. This could be a possible cause of the reduced GSH in some groups in our study as the experimental diets were difficient in the amino acid cysteine, the rate limiting amino acid for GSH synthesis. The present data also showed that hepatic GSH was restored by wheat flour-based diets. Similar improving effects on blood and tissue redox status were obtained after feeding bioactive polyphenolic compounds from winery wastes to broilers \[[@bib0500]\], also the antioxidative capacity was improved by feeding byproducts from olive mill wastwater to chickens \[[@bib0505]\], or to piglets \[[@bib0510]\].

Results of activities of antioxidant enzymes in the course of DM are equivocal and seem to depend on the duration and the control of diabetes \[[@bib0515]\]. In the present study, the inhibition of hepatic CAT activity in all diabetic rats versus healthy control could be attributed to hyperglycaemia-induced oxidative stress. Several studies support our data and demonstrate that alloxan-induced reduction in antioxidant enzymes activites during the course of type I DM in the liver, pancreas and testes \[[@bib0485], [@bib0515], [@bib0520]\].

Increased eSOD activity in diabetic control rats have been shown by this study and confirms others' findings in animals *in vivo* \[[@bib0525]\] and in human \[[@bib0530]\]. The increased diabetic control eSOD activity reported in our study might be a manifestation of an adaptive response. The effect of tested diets on eSOD level was variable. As well, might be related to the increased absorption of zinc as reported by \[[@bib0480], [@bib0535]\]. Zbronska et al. \[[@bib0540]\] reported a close correlation between eSOD activity and its cofactors, both Cu and Zn. Riddoch et al. \[[@bib0545]\] reported that germination increases ascorbic acid content of seeds, and eventually may reduce oxidative stress-mediated eSOD increment in erythrocytes of diabetic animals. Sundaram et al. \[[@bib0480]\] suggested that the inactivation of eSOD by glycosylation may be a dominant factor in the loss of eSOD activity among diabetic patients due to the absence of protein synthesizing machinery in the erythrocytes.

The present study demonstrated no difference in plasma −SH groups between healthy and diabetic controls. This goes in accordance with Ceriello et al. \[[@bib0550]\] in his study on diabetic patients, and confilcted with \[[@bib0555]\] who demonstrated unaltered −SH level in STZ-diabetic rats, which could be attributed to the difference in the assay method. Another possible cause of the diminshed −SH groups in our study is the oxidized methionine levels that are likely to increase further with diabetes \[[@bib0110]\].

Plasma α-T level was significantly higher in diabetic control versus healthy control groups. The dietary intervention reduced the increased levels compared to the diabetic control. Our results agree with \[[@bib0555], [@bib0560]\] and contradict with \[[@bib0550], [@bib0565]\]. The discripancies among reports are likely to rely on the experimental conditions such as duration and stage of diabetes.

The significant elevation of plasma α-T reported in our diabetic control rats is consistent with the findings of \[[@bib0370], [@bib0570], [@bib0525]\]. The diminshed plasma α-T levels in most experimental rats could be due to improved lipid pattern, evidenced in our data, [Fig. 5](#fig0025){ref-type="fig"}. In addition to the increased consumption of α-T in reducing the elevated oxidative stress as evidenced by reduced hepatic MDA marker in such groups.

Önning et al. \[[@bib0575]\] studied the effect of oatmilk, soymilk, and cow's milk on plasma lipid, glucose, insulin and antioxidant status of 24 healthy men and women. Consumption of (0.75--1 l/day of oatmilk and soymilk for 4 weeks each) resulted in decreased total and plasma LDL-cholesterol with no effect on HDL-cholesterol. Also a higher glucose value was observed for women but lower for men consuming soymilk. Insulin values tended to increase when the subjects consumed soymilk compared to oat milk. However, no effect of soymilk on serum antioxidant status was observed.

In the present study, feeding whole wheat-based diets improved the deteriorated oxidative status of AD rats. This effect was manifested by marked decrease in hepatic MDA accompanied by an increase in hepatic GSH content, plasma α-T and eSOD levels. Such effect could be attributed to a reduction in hyperglycaemia-induced oxidative stress and/or the efficient antioxdative action of total carotenoids and tocopherol that exist in wheat grain and in the germ oil \[[@bib0580]\]. Others\' findings support our suggestion \[[@bib0585], [@bib0485]\]. Whole wheat diets induced an increase in hepatic GSH content, which may enhance the GSH/GSSG ratio, decrease hepatic lipid peroxidation and improve serum glucose regulation.

The available studies indicate that soy isoflavones have antioxidant effects *in vitro* \[[@bib0395]\], as well as *in vivo* \[[@bib0590]\]. Those studies suggest that soy isoflavones are transported in LDL and act like vitamin E to inhibit *in vivo* oxidation. In this study, the antioxidative properties of soy isoflavones were apparent only in the group fed heat-processed soybean diet, since hepatic MDA was significantly decreased accompanied by alterations in the antioxidant measures. This is inconsistent with the results of \[[@bib0205]\], suggesting that the *in vitro* antioxidative effects of soy isoflavones are somewhat unclear.

Our findings reveals that diabetes induced the expected changes in the lipid profile while soybeans and wheat lowered TAGs and tended to lower total cholesterol. Germination enhanced the effect of soybeans on TAGs and in the case of soy and wheat, enhanced the effect on total cholesterol, [Fig. 5](#fig0025){ref-type="fig"}. Although the effectiveness of whole wheat flour in digestive fermentation and lipid metabolism has not been established, rats fed the whole wheat flour diets had the fecal excretion of the total steroids markedly enhanced \[[@bib0595]\].

Several studies, as well as the present one, have shown that chronic sever DM in rats \[[@bib0600], [@bib0605]\] and in human \[[@bib0610]\] results in hyperlipidemia \[[@bib0615]\]. Our data shows that the elevated plasma total cholesterol was significantly decreased only in germinated soybean, germinated wheat or dried wheat fed groups. Similarly, plasma TAGs levels were significantly lowered even below the normal control level in groups fed soybean or whole wheat diets. The exact mechanism of the hypocholesterolemic effect of soy protein remains elusive and is almost certain to be multifactorial. Soybean protein has no cholesterol, it has the effect of increasing fecal bile acid excretion and altering bile acid synthesis rates, one of the primary mechanisms responsible for the regulation of cholesterol homeostasis, hepatic cholesterol secretion is also increased \[[@bib0620]\].

In our study, the observed effect of wheat on serum lipids is consistent with the findings of other authors \[[@bib0595], [@bib0625]\] who attributed this effect to the fiber and protein content of wheat.

Our results revealed no difference in UA between healthy and diabetic controls. Our findings agrees with \[[@bib0555]\] on STZ-diabetic rats and in diabetic patients \[[@bib0630]\]. Several studies have shown an association between hyperuricaemia and diabetes and suggested that UA increases insulin reistance \[[@bib0410], [@bib0635]\]. Our data showed that the tested diets-induced reduction in UA levels, which could be traced to decreased synthesis of UA due to the diminshed intake of purine nucleotides, or to the marked improvement in blood glucose by most of the experimental diets.

The present data also showed that a germinated broadbean diet induced partial improvement in the elevated hepatic MDA content of diabetic rats, associated with insignificant alterations in the other antioxidants measured. However, a heat-processed broadbean diet brought about significant decrease in UA and α-T levels. Unlike soybean, broadbean is poor in phytochemicals and its fat content averages only 1% by weight, with unsaturated fatty acids predominating \[[@bib0640]\]. Thus, the mildly ameliorative effects on the oxidative status of diabetic rats may be related to the various components present in the broadbean such as fibers, saponins and phytosterols.

5. Limitations {#sec0120}
==============

We were limited by the available resources of conducting a histopathological analysis of the oxidative stress markers in the studied tissues, of measuring the average water intake by animals and of measuring glucose tolerance, insulin tolerance and the exact lean and fat mass composition before and after serving the experimental diets. Including an insulin-treated control group would have addressed the glycemic effects in general, but would not have helped tracing such curative effect to soy proteins or to phytochemicals. The same applies to the other experimental diets we used in our study model. We could not determine glycosylated hemoglobin HbA1c, a diabetes marker, for financial concerns. Our extended current research will take such valuable comments into account.

6. Significance and conclusion {#sec0125}
==============================

This study is of considerable implication. Consumption of soybean and whole wheat beneficially affect the antioxidative status and lipid pattern of AD rats. Based on such findings, we recommend that diabetic patients, beside controlling their hyperglycaemia with medications, may include whole foods containing naturally occurring phytochemicals to ameliorate their oxidative status.
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[^1]: Choline chloride (0.5 ml of 20% solution/100 g diet) was added to all diets. Cod liver oil to supply 2000 IU vitamin A, 200 IU vitamin D were added to all diets at the expense of sunflower oil.

[^2]: All the ingredients of the vitamin mixture were purchaced from Sigma.

[^3]: Soy flours used were full fat.

[^4]: According to Campbell et al. (1963).

[^5]: According to Hegsted et al. (1941).

[^6]: According to AOAC. The Association of Official Analytical Chemists Incorporation. Arlington, Virginia, USA \[[@bib0265]\].

[^7]: G = Group. Number of rats per group is presented between parentheses.
